AAAAAA

   
Results: 1-18 |
Results: 18
ONCOSTATIN-M STIMULATES EXCESSIVE EXTRACELLULAR-MATRIX ACCUMULATION IN A TRANSGENIC MOUSE MODEL OF CONNECTIVE-TISSUE DISEASE
Authors: BAMBER B REIFE RA HAUGEN HS CLEGG CH
Citation: B. Bamber et al., ONCOSTATIN-M STIMULATES EXCESSIVE EXTRACELLULAR-MATRIX ACCUMULATION IN A TRANSGENIC MOUSE MODEL OF CONNECTIVE-TISSUE DISEASE, Journal of molecular medicine, 76(1), 1998, pp. 61-69
LOCAL CHEMOKINE PARALYSIS, A NOVEL PATHOGENIC MECHANISM FOR PORPHYROMONAS-GINGIVALIS
Authors: DARVEAU RP BELTON CM REIFE RA LAMONT RJ
Citation: Rp. Darveau et al., LOCAL CHEMOKINE PARALYSIS, A NOVEL PATHOGENIC MECHANISM FOR PORPHYROMONAS-GINGIVALIS, Infection and immunity, 66(4), 1998, pp. 1660-1665
GENE-EXPRESSION OF COLLAGEN-TYPE-IIA AND COLLAGEN-TYPE-IX CORRELATES WITH ULTRASTRUCTURAL EVENTS IN EARLY OSTEOARTHROSIS - NEW APPLICATIONSOF THE RABBIT MENISCECTOMY MODEL
Authors: LEFKOE TP NALIN AM CLARK JM REIFE RA SUGAI J SANDELL LJ
Citation: Tp. Lefkoe et al., GENE-EXPRESSION OF COLLAGEN-TYPE-IIA AND COLLAGEN-TYPE-IX CORRELATES WITH ULTRASTRUCTURAL EVENTS IN EARLY OSTEOARTHROSIS - NEW APPLICATIONSOF THE RABBIT MENISCECTOMY MODEL, Journal of rheumatology, 24(6), 1997, pp. 1155-1163
TOPIRAMATE MONOTHERAPY FOR PARTIAL ONSET SEIZURES
Authors: SACHDEO RC REIFE RA LIM P PLEDGER G
Citation: Rc. Sachdeo et al., TOPIRAMATE MONOTHERAPY FOR PARTIAL ONSET SEIZURES, Epilepsia, 38(3), 1997, pp. 294-300
TOPIRAMATE AS ADJUNCTIVE THERAPY IN REFRACTORY PARTIAL EPILEPSY - POOLED ANALYSIS OF DATA FROM 5 DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
Authors: REIFE RA PLEDGER GW
Citation: Ra. Reife et Gw. Pledger, TOPIRAMATE AS ADJUNCTIVE THERAPY IN REFRACTORY PARTIAL EPILEPSY - POOLED ANALYSIS OF DATA FROM 5 DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS, Epilepsia, 38, 1997, pp. 31-33
TOPIRAMATE PLACEBO-CONTROLLED DOSE-RANGING TRIAL IN REFRACTORY PARTIAL EPILEPSY USING 200-MG, 400-MG, AND 600-MG DAILY DOSAGES
Authors: FAUGHT E WILDER BJ RAMSAY RE REIFE RA KRAMER LD PLEDGER GW KARIM RM BARR A FISCHER J BERGEN D BOOR D BROWNE T DAVENPORT J DICHTER M DRAKE M KUZNIECKY R MAMDANI M MCCUTCHEN C NARITOKU D POTOLICCHIO S RAMANI V RAMSAY R SHINNAR S SO E WILDER B
Citation: E. Faught et al., TOPIRAMATE PLACEBO-CONTROLLED DOSE-RANGING TRIAL IN REFRACTORY PARTIAL EPILEPSY USING 200-MG, 400-MG, AND 600-MG DAILY DOSAGES, Neurology, 46(6), 1996, pp. 1684-1690
AN OPEN-LABEL MULTICENTER STUDY OF TOPIRAMATE IN PATIENTS WITH THE LENNOX-GASTAUT SYNDROME
Authors: FRENCH JA BOURGEOIS BFD DREIFUS FE GLAUSER TA RITTER RJ REIFE RA SHEILDS WD CONOVER D
Citation: Ja. French et al., AN OPEN-LABEL MULTICENTER STUDY OF TOPIRAMATE IN PATIENTS WITH THE LENNOX-GASTAUT SYNDROME, Neurology, 45(4), 1995, pp. 250-250
PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE IS POORLY RECOGNIZED BY MOLECULAR-COMPONENTS OF INNATE HOST-DEFENSE IN A MOUSE MODEL OF EARLY INFLAMMATION
Authors: REIFE RA SHAPIRO RA BAMBER BA BERRY KK MICK GE DARVEAU RP
Citation: Ra. Reife et al., PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE IS POORLY RECOGNIZED BY MOLECULAR-COMPONENTS OF INNATE HOST-DEFENSE IN A MOUSE MODEL OF EARLY INFLAMMATION, Infection and immunity, 63(12), 1995, pp. 4686-4694
TOPIRAMATE - DOUBLE-BLIND TRIAL AS MONOTHERAPY
Authors: SACHDEO SK SACHDEO RC REIFE RA LIM P PLEDGER G
Citation: Sk. Sachdeo et al., TOPIRAMATE - DOUBLE-BLIND TRIAL AS MONOTHERAPY, Epilepsia, 36, 1995, pp. 8-8
TOPIRAMATE DOSE-RANGING TRIAL IN REFRACTORY PARTIAL EPILEPSY
Authors: FAUGHT E WILDER BJ RAMSAY RE REIFE RA KRAMER LD PLEDGER GW KARIM RM
Citation: E. Faught et al., TOPIRAMATE DOSE-RANGING TRIAL IN REFRACTORY PARTIAL EPILEPSY, Epilepsia, 36, 1995, pp. 9-9
TOPIRAMATE - SIDE-EFFECT PROFILE IN DOUBLE-BLIND STUDIES
Authors: REIFE RA LIM P PLEDGER G
Citation: Ra. Reife et al., TOPIRAMATE - SIDE-EFFECT PROFILE IN DOUBLE-BLIND STUDIES, Epilepsia, 36, 1995, pp. 10-10
OVERVIEW OF TOPIRAMATE EFFICACY FROM ADJUNCTIVE THERAPY TRIALS
Authors: PLEDGER G REIFE RA LIM P KARIM R
Citation: G. Pledger et al., OVERVIEW OF TOPIRAMATE EFFICACY FROM ADJUNCTIVE THERAPY TRIALS, Epilepsia, 36, 1995, pp. 150-150
TOPIRAMATE - PK PD ANALYSES
Authors: REIFE RA PLEDGER G DOOSE D LIM P WARD C
Citation: Ra. Reife et al., TOPIRAMATE - PK PD ANALYSES, Epilepsia, 36, 1995, pp. 152-152
NEPHROLITHIASIS DURING TREATMENT WITH TOPIRAMATE
Authors: WASSERSTEIN AG RAK I REIFE RA
Citation: Ag. Wasserstein et al., NEPHROLITHIASIS DURING TREATMENT WITH TOPIRAMATE, Epilepsia, 36, 1995, pp. 153-153
INVESTIGATION OF THE MECHANISTIC BASIS FOR TOPIRAMATE-ASSOCIATED NEPHROLITHIASIS - EXAMINATION OF URINARY AND SERUM CONSTITUENTS
Authors: WASSERSTEIN AG RAK I REIFE RA
Citation: Ag. Wasserstein et al., INVESTIGATION OF THE MECHANISTIC BASIS FOR TOPIRAMATE-ASSOCIATED NEPHROLITHIASIS - EXAMINATION OF URINARY AND SERUM CONSTITUENTS, Epilepsia, 36, 1995, pp. 153-153
EVALUATION OF PHENOBARBITAL AND PRIMIDONE PHENOBARBITAL (PRIMIDONES ACTIVE METABOLITE) PLASMA-CONCENTRATIONS DURING ADMINISTRATION OF ADD-ON TOPIRAMATE THERAPY IN 5 MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS IN OUTPATIENTS WITH PARTIAL SEIZURES
Authors: DOOSE DR WALKER SA PLEDGER G LIM P REIFE RA
Citation: Dr. Doose et al., EVALUATION OF PHENOBARBITAL AND PRIMIDONE PHENOBARBITAL (PRIMIDONES ACTIVE METABOLITE) PLASMA-CONCENTRATIONS DURING ADMINISTRATION OF ADD-ON TOPIRAMATE THERAPY IN 5 MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS IN OUTPATIENTS WITH PARTIAL SEIZURES, Epilepsia, 36, 1995, pp. 158-158
STEADY-STATE PHARMACOKINETICS OF TOPIRAMATE AS ADJUNCTIVE THERAPY IN PEDIATRIC SUBJECTS WITH EPILEPSY
Authors: ROSENFELD WE DOOSE DR WALKER SA SCHAEFER P REIFE RA
Citation: We. Rosenfeld et al., STEADY-STATE PHARMACOKINETICS OF TOPIRAMATE AS ADJUNCTIVE THERAPY IN PEDIATRIC SUBJECTS WITH EPILEPSY, Epilepsia, 36, 1995, pp. 158-158
ALTERNATIVE SPLICE FORM OF TYPE-II PROCOLLAGEN MESSENGER-RNA (IIA) ISPREDOMINANT IN SKELETAL PRECURSORS AND NON-CARTILAGINOUS TISSUES DURING EARLY MOUSE DEVELOPMENT
Authors: SANDELL LJ NALIN AM REIFE RA
Citation: Lj. Sandell et al., ALTERNATIVE SPLICE FORM OF TYPE-II PROCOLLAGEN MESSENGER-RNA (IIA) ISPREDOMINANT IN SKELETAL PRECURSORS AND NON-CARTILAGINOUS TISSUES DURING EARLY MOUSE DEVELOPMENT, Developmental dynamics, 199(2), 1994, pp. 129-140
Risultati: 1-18 |